SCHEMBL22311097

SCHEMBL22311097

CCNC(=O)c1ccc(OCCCCC2CCN(C(=O)C(O)(c3ccccc3)C(F)(F)F)CC2)cc1Cl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR1H2 P55055 2/20 0.47
▸ NR1H3 Q13133 2/20 0.47
▸ THRB P10828 2/20 0.40
▸ ALDH1A1 P00352 1/20 0.38
▸ CHRM2 P08172 3/20 0.38
▸ CHRM3 P20309 3/20 0.38
▸ CHRM5 P08912 2/20 0.38
▸ CHRM1 P11229 2/20 0.38
▸ MAOA P21397 2/20 0.38
▸ BCHE P06276 1/20 0.38
▸ ACHE P22303 1/20 0.38
▸ MAOB P27338 1/20 0.38
▸ MEN1 O00255 1/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ PTGIR P43119 1/20 0.37
▸ PDK2 Q15119 1/20 0.37
▸ USP2 O75604 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22311354 1.00 NR1H2 (0.47) NR1H2NR1H3THRBALDH1A1CHRM2
SCHEMBL30451661 1.00 NR1H2 (0.47) NR1H2NR1H3THRBALDH1A1CHRM2
SCHEMBL30452088 0.91 NR1H2 (0.45) NR1H2NR1H3THRBALDH1A1CHRM2
SCHEMBL22284416 0.91 NR1H2 (0.45) NR1H2NR1H3THRBALDH1A1CHRM2
SCHEMBL22284418 0.91 NR1H2 (0.45) NR1H2NR1H3THRBALDH1A1CHRM2
SCHEMBL22311362 0.91 NR1H2 (0.45) NR1H2NR1H3THRBALDH1A1CHRM2
SCHEMBL30451522 0.90 NR1H2 (0.50) NR1H2NR1H3THRBCHRM2CHRM3
SCHEMBL22311050 0.90 NR1H2 (0.50) NR1H2NR1H3THRBCHRM2CHRM3
SCHEMBL22311054 0.90 NR1H2 (0.48) NR1H2NR1H3THRBALDH1A1CHRM2
SCHEMBL30451273 0.90 NR1H2 (0.48) NR1H2NR1H3THRBALDH1A1CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200247754-A1 ARYL AND HETEROARYL ETHER DERIVATIVES AS LIVER X RECEPTOR BETA AGONISTS, COMPOSITIONS, AND THEIR USE MERCK SHARP & DOHME CORP. (US) 2020-08-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200247754-A1 ARYL AND HETEROARYL ETHER DERIVATIVES AS LIVER X RECEPTOR BETA AGONISTS, COMPOSITIONS, AND THEIR USE NR1H2, NR1H3, NR1H4 NR1H2 1/4885NR1H3 2/4885THRB 192/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback